Patient Satisfaction Scale Research Articles

COMPARATIVE OF SOCIO-DEMOGRAPHIC FACTORS THAT INFLUENCE NURSES’ COMMUNICATION DURING PREOPERATIVE PREPARATION OF SURGICAL PATIENTS IN SELECTED HOSPITAL IN OGBOMOSO

This study identifies the socio-demographic factors that influence nurses' communication and patients' satisfaction during the preoperative preparation of surgical patients in Ladoke Akintola University Teaching Hospital (LTH) and Bowen University Teaching Hospital (BUTH) in Ogbomoso. A cross sectional descriptive-correctional research design was employed for this study. A total of 170 surgical patients, which involved 100 and 70 patients at Ladoke Akintola University Teaching Hospital (LTH) and Bowen University Teaching Hospital (BUTH) in Ogbomoso were used respectively for this study and assessed using adopted questionnaires – Nurse Quality of Communication with Patient Questionnaire (NQCPQ) to assess the nurses’ communication and the La Monica Oberst Patient Satisfaction Scale (LOPSS) for patients’ satisfaction. Data obtained were analysed using Statistical Product and Service Solutions (SPSS) version 25. Descriptive analysis was expressed as Mean ± Standard deviation, using frequency Table, Multivariate linear regression and Pearson correlation were used for inferential statistics and the test of hypothesis, Statistical significance was determined at P<0.05. Findings showed high scores of nurse’s communication at LTH (105.51 ± 19.47) and BUTH (112.73 ± 20.00), indicate good quality of nurses’ communication. The total LOPSS score showed that moderate patients’ satisfactions across the hospitals with LTH (169.43 ± 35.32) and BUTH (177.89 ± 24.67). Multivariate linear regression analysis showed that at p<0.05, income level at LTH; marital status, religion, and knowing the name(s) of attending nurse(s) at BUTH significantly influenced nurse’s communication. Employment status and type of surgery at LTH; income level at BUTH; significantly influenced patient satisfaction (p<0.05). Nurse communication significantly correlates patient satisfaction in LTH. No significant correlation was found in BUTH, suggesting that context-specific factors may moderate the impact of nurse communication on patient satisfaction. However, the results in this research work is recommended for use in the health institutions.

Efficacy of intralesional pentoxifylline versus intralesional steroid versus intralesional vitamin D in treatment of keloid.

Several treatment modalities have been used for the treatment of keloid scarring but the optimal treatment has not yet been identified. Corticosteroids reduce excessive scarring by reducing collagen synthesis. Vitamin D can curb inflammation by inhibiting the activation and migration of leukocytes. Pentoxifylline is a methyl xanthine derivative initially developed for its vasodilatory properties. Evaluation and comparison between three modalities of treatment for keloid; intralesional vitamin D, pentoxifylline, and steroid. Forty-five patients with keloid lesions were divided into 3 groups; The first group: 15 patients were treated with intralesional triamcinolone acetonide. The second group: 15 patients treated with intralesional pentoxifylline. The third group: 15 patients treated with intralesional vitamin D. The response was evaluated clinically, Vancouver scar scale and patient satisfaction scale. At the end of the study, all groups showed highly statistically significant improvement compared to the baseline. The first group which was treated with triamcinolone acetonide showed excellent and good improvement 53% and 47% respectively. The second group which was treated with pentoxifylline showed excellent and good improvement 6.7% and 73.3% respectively. The third group which was treated with vitamin D showed excellent and good 6.7% and 86.7% respectively. Intralesional vitamin D and pentoxifylline are safe and effective therapeutic options for keloid lesions.

Validation of the Brief Emergency Department Patient Satisfaction Scale in Hungary

Validation of the Brief Emergency Department Patient Satisfaction Scale in Hungary

Comparing the clinical efficacy of preganglionic and preganglionic plus ganglionic transforaminal epidural steroid injections for lumbosacral radicular pain.

To compare the effectiveness of preganglionic transforaminal epidural steroid injection (TFESI) with preganglionic plus postganglionic TFESI. Patients with unilateral radicular pain and disc pathology were randomly assigned to either the preganglionic group or the preganglionic plus postganglionic group. All patients were evaluated using a numeric rating scale (NRS) and a patient satisfaction scale (PSS) at the third week and the third month after treatment. There were significant differences between the patients' NRS scores after TFESI for both groups. In terms of >50% pain relief at three weeks and 3 months post-treatment, no significant differences were found between the groups (p>0.05). The PSS scores of the preganglionic plus postganglionic group were significantly lower at third month than at the third week (p=0.046). The PSS scores of the two groups were similar at third week and third month (p>0.05). A weak negative correlation was found between age and meaningful pain relief at the third month (Rho=.278, p=0.024). A moderate positive correlation was found between meaningful pain relief at the third week and meaningful pain relief the third month (Rho=.465, p<0.001). Male gender showed a weak positive correlation with meaningful pain relief at the third week (Rho=.281, p=0.022) and the third month (Rho=.256, p=0.038) CONCLUSION: The combined preganglionic plus postganglionic approach for TFESI did not affect the outcomes in patients with unilateral discogenic radicular pain. The preganglionic TFESI approach alone at the disc level was sufficient to achieve pain relief.

Efficacy of tranexamic acid solution versus vitamin C solution after micro-needling in treatment of persistent post acne erythema: a split face clinical and 3DAntera camera comparative study.

Post acne erythema (PAE) is a common sequela of acne inflammation, and it refers to telangiectasia and erythematous lesions remaining after the acne treatment. Although some PAE may improve over time, persisting PAE might be esthetically undesirable for patients. The efficacy of various treatment options for PAE has been investigated in many studies but there exists no gold standard treatment modality. This current split face comparative study aimed to assess and compare the therapeutic efficacy of vitamin c solution 10% with microneedling versus Tranexamic acid solution (TXA) (50mg/ml) with microneedling in treating patients with PAE. Four sessions were held, two weeks apart. The assessment was done 2 weeks after the last session via change in Clinical Erythema Assessment (CEA) score, Antera 3D camera parameter changes (average hemoglobin level and hemoglobin variation), and patient satisfaction scale. Also, side effects were documented. Our study showed that both topical vitamin C and TXA solutions after microneedling showed significant decrease in hemi-CEA score and Antera camera measures of both Hb variations and average Hb levels. However, TXA treated side showed superior improvement than the side treated with vitamin c. Also, there was great patient satisfaction on both treated sides. The side effects reported were transient and minimal. Microneedling with TXA solution is a safe, effective and readily available modality of PAE treatment and showed superior results over vitamin C solution. Antera 3D camera is an excellent objective tool for assessing even minimal changes in Hb level and variation.

The Impact of an Early Mobility Protocol on Recovery Outcomes in Patients Undergoing Abdominal Surgeries.

According to the World Health Organization (WHO), early mobilization is a critical component of healthcare that significantly impacts patient recovery and outcomes. Despite evidence supporting the benefits of early mobilization for abdominal surgery patients, standardized protocols remain scarce across many healthcare environments. This study evaluates the feasibility and impact of an early mobility protocol (EMP) on improvement in mobility and patient satisfaction in abdominal surgery patients. This feasibility study, conducted in the surgical intensive care unit at Health World Hospital in West Bengal, involved 20 participants who underwent abdominal surgery. Data were collected via demographic questionnaires, the Modified Johns Hopkins Highest Level of Mobility scale, and a patient satisfaction scale. Statistical analysis was performed using IBM Statistical Package for the Social Sciences Statistics, version 28.0, Armonk, NY. The EMP significantly enhanced recovery outcomes among patients undergoing abdominal surgery. By day 6, sixout of 10 participants in the experimental group(EG; 60%) achieved independence in mobility, compared to five out of 10 participants (50%) in the control group. Additionally, the protocol led to substantially higher mobility scores (p = 0.0001) and patient satisfaction levels, with the EG reporting an average satisfaction score of 4.40, markedly higher than the 0.70 observed in the control group (p < 0.05), thus underscoring the protocol's effectiveness. This study demonstrates that an EMP significantly enhances recovery outcomes for abdominal surgery patients, with 60% (six out of 10) of the EG achieving independence by day 6. However, the lack of standardized early mobilization protocols in healthcare settings remains a critical gap. These results align with the WHO's recommendations, underscoring early mobilization as a cornerstone of postoperative recovery and emphasizing the need for standardized approaches to optimize patient outcomes.

The Effect of Video Streaming With Virtual Reality Glasses on on Pain Anxiety and Satisfaction Applied in Peripheral Intravenous Catheter Process

Peripheral intravenous catheter (PIC) implementation is among the most frequent and highly invasive nursing initiatives. PIC leads to anxiety with procedural pain, causing individuals to reject these procedures or negatively affecting the process's success. The study was conducted to determine the effect of virtual reality glasses (VRG) on pain, anxiety, and patient satisfaction during the peripheral intravenous catheter (PIC) process in adults. An experimental study. An emergency department of a university hospital. Individuals who were admitted to the emergency unit of the university hospital were recruited between the data collection dates. Data from individuals' "Patient Information Form," "Visual Pain Scale," "Visual Anxiety Scale," and "Visual Satisfaction Scale" were collected. "VR-Box 3D Glasses" was used as virtual reality glasses. In our study, when the pain point averages with VAS were compared during the PIC process, the pain score average of the patients in the control group was 5.78 ± 1.23 visual anxiety scale 5.89 ± 1.23 and patient satisfaction scale 3.86 ± 2.48, The visual pain score average of patients in the VRG group is 4.12 ± 2.16, visual anxiety scale 3.14 ± 1.76 and visual patient satisfaction scale 7.64 ± 3.26. In short, it has been detected that the pain, anxiety, and patient satisfaction score averages of patients in the VRG group are statistically significant compared to the pain score averages of patients in the control group (p < .005). Our study unearthed a statistically significant relationship at an average level of negative direction between PIC post-treatment pain, anxiety, and patient satisfaction (r = - 0.476). Utilization of VRG has been detected to reduce pain and anxiety felt during the PIC process in adult patients and increase process satisfaction. VRG, a non-pharmacological, non-invasive, inexpensive, and feasible nursing initiative, may be recommended for use in pain and anxiety control in patients undergoing PIC treatment.

Narrative nursing for negative emotions in patients with acute pancreatitis: Based on model construction and application.

Acute pancreatitis (AP), as a common acute abdomen disease, has a high incidence rate worldwide and is often accompanied by severe complications. Negative emotions lead to increased secretion of stress hormones, elevated blood sugar levels, and enhanced insulin resistance, which in turn increases the risk of AP and significantly affects the patient's quality of life. Therefore, exploring the intervention effects of narrative nursing programs on the negative emotions of patients with AP is not only helpful in alleviating psychological stress and improving quality of life but also has significant implications for improving disease outcomes and prognosis. To construct a narrative nursing model for negative emotions in patients with AP and verify its efficacy in application. Through Delphi expert consultation, a narrative nursing model for negative emotions in patients with AP was constructed. A non-randomized quasi-experimental study design was used in this study. A total of 92 patients with AP with negative emotions admitted to a tertiary hospital in Nantong City of Jiangsu Province, China from September 2022 to August 2023 were recruited by convenience sampling, among whom 46 patients admitted from September 2022 to February 2023 were included in the observation group, and 46 patients from March to August 2023 were selected as control group. The observation group received narrative nursing plan, while the control group was given with routine nursing. Self-rating anxiety scale (SAS), self-rating depression scale (SDS), positive and negative affect scale (PANAS), caring behavior scale, patient satisfaction scale and 36-item short form health survey questionnaire (SF-36) were used to evaluate their emotions, satisfaction and caring behaviors in the two groups on the day of discharge, 1-and 3-month following discharge. According to the inclusion and exclusion criteria, a total of 45 cases in the intervention group and 44 cases in the control group eventually recruited and completed in the study. On the day of discharge, the intervention group showed significantly lower scores of SAS, SDS and negative emotion (28.57 ± 4.52 vs 17.4 ± 4.44, P < 0.001), whereas evidently higher outcomes in the positive emotion score, Caring behavior scale score and satisfaction score compared to the control group (P < 0.05). Repeated measurement analysis of variance showed that significant between-group differences were found in time effect, inter-group effect and interaction effect of SAS and PANAS scores as well as in time effect and inter-group effect of SF-36 scores (P < 0.05); the SF-36 scores of two groups at 3 months after discharge were higher than those at 1 month after discharge (P < 0.05). The application of narrative nursing protocols has demonstrated significant effectiveness in alleviating anxiety, ameliorating negative emotions, and enhancing satisfaction among patients with AP.

Multicentre randomised controlled trial comparing Bankart repair with remplissage and Latarjet procedure in shoulder instability with subcritical bone loss (STABLE): study protocol

IntroductionRecurrent shoulder dislocations often cause attrition of the labrum and progressive loss of the anterior bony contour of the glenoid. Treatment options for this pathology involve either soft tissue repair...

Facial Gold Reinforcement: 28 Years of Experience in the Use of Gold Threads

Introduction: Gold threads became widely used in esthetic surgery in the early 1990s. Produced in Spain, these threads consisted of a gold thread (5/0) with a diameter of 0.1 mm, composed of 99.99% pure gold, which was combined with a polyglycolic thread. Since then, discussions about their effectiveness have continued, which is the focus of our study. Patients and Methods: Gold thread implantation was performed on 11,062 patients in four clinics in Moscow over the course of 28 years. This study used a comparative analysis of photo collages created for the visual representation of data and changes before and after the procedure, as well as patient satisfaction assessments using the Patient Satisfaction Scale (PSS). We examined the results of 492 patients who underwent gold thread implantation in the face between 1996 and 2024. Of these patients, 86% were women aged 30 to 60 years, 11% were women aged 20 to 30 years, and 3% were men aged 25 to 60 years. Results: One year after thread implantation, the PSS assessment showed a 91% success rate with minimal complications. Patient satisfaction was high, with an average score of 4.8 out of 5 after one month, 4.7 after six months, and 4.6 after one-year post-procedure. Discussion: Gold thread implantation is a minimally invasive procedure that has demonstrated a high level of safety, making it an effective option for facial rejuvenation. Histological studies have shown that gold threads stimulate the production of collagen and elastin and activate angiogenesis, thereby improving skin nourishment and hydration, as well as enhancing the skin tone, elasticity, and turgor. To improve the qualitative characteristics of the skin, it is necessary to work in the subcutaneous layer. Conclusions: Gold thread implantation strengthens the connective tissue framework at the implantation site, thus improving skin nourishment and hydration. Gold threads provide a long-term rejuvenating effect, slowing the ptosis of the soft tissue of the face and neck. Gold thread implantation does not interfere with tissue dissection during surgical interventions or the performance of any cosmetic procedures, including hardware-based treatments.

Efficacy and Complications of Full Dose versus Half Dose of Botulinum Toxin Type A Injection in Benign Essential Blepharospasm

Objective: To compare the effectiveness, patient satisfaction, and complications associated with pretarsal botulinum toxin type A (BTX-A) injections using half versus full doses of benign essential blepharospasm (BEB). Materials and Methods: A prospective double-masked randomized control trial was conducted in 20 patients. Each patient was randomized to receive either 40 or 80 units of BTX-A injections at Thammasat Hospital between April 2022 and August 2023. The primary outcome measures were frequency and severity using the Jankovic Rating Scale (JRS), latency to response, self-response scale, and patient satisfaction scale at four weeks and 12 weeks post-injection. The secondary outcome measures were complications of injection in each visit. Results: There were no significant differences between the groups receiving half-dose and full-dose BTX-A injections in the self-response scale at 2.60±0.52 versus 2.00±1.15, (p=0.277), patient satisfaction scale at 8.30±1.57 versus 7.00±1.49, (p=0.063) at four weeks and JRS frequency at 1.00±0.82 versus 1.20±0.92, (p=0.687), JRS severity at 1.30±1.16 versus 1.40±0.97, (p=0.784), latency to response at 5.80±1.99 versus 6.80±1.93, (p=0.214), self-response scale at 2.70±0.48 versus 2.20±0.63, (p=0.067), and patient satisfaction scale at 8.10±1.60 versus 8.30±1.49, (p=0.776) at 12 weeks. Complications, including epiphora, dry eye, and lagophthalmos, were observed in both groups. Conclusion: The present study indicated no significant differences between half-dose and full-dose BTX-A injections. Either dose showed comparable efficacy and safety in treating BEB. Trial registration: The present study protocol was registered at the Thai Clinical Trials Registry (TCTR20240320002; date March 20, 2024).

7377 CAM2029, Octreotide Subcutaneous Depot, Improves Patient-Reported Outcomes From Standard-of-Care Baseline in Patients With Acromegaly: Interim Results From a Phase 3 Study (ACROINNOVA 2)

Abstract Disclosure: D. Ferone: Consulting Fee; Self; Camurus AB, Ipsen, Novartis-AAA, Recordati. Grant Recipient; Self; Camurus AB, Ipsen, Novartis-AAA, Recordati. Research Investigator; Self; Camurus AB. P. Maffei: Research Investigator; Self; Camurus AB. J. Silverstein: Consulting Fee; Self; Xeris Pharmaceuticals. Research Investigator; Self; Camurus AB. J.L. Spencer-Segal: Advisory Board Member; Self; Camurus AB. Research Investigator; Self; Camurus AB. A. Gilis-Januszewska: None. M. Doknic: Speaker; Self; Pfizer, Inc., Novo Nordisk, Merck, Sandoz. P. Kadioglu: None. P. Freda: Research Investigator; Self; Camurus AB. L. Katznelson: Advisory Board Member; Self; Camurus AB, Recordati. G. Fidan Yaylali: None. M. Harrie: Employee; Self; Camurus AB. Stock Owner; Self; Camurus AB. A. Svedberg: Employee; Self; Camurus AB. Stock Owner; Self; Camurus AB. A.M. Pedroncelli: Employee; Self; Camurus AB. Stock Owner; Self; Camurus AB. F. Tiberg: Employee; Self; Camurus AB. Stock Owner; Self; Camurus AB. Introduction: Standard-of-care (SoC) therapies for acromegaly typically require healthcare provider administration and can pose a significant treatment burden. CAM2029 is a novel subcutaneous octreotide depot designed for convenient once-monthly self-administration as a ready-to-use syringe or injection pen. In a 24-week Phase 3 trial (ACROINNOVA 1), CAM2029 achieved superior insulin-like growth factor 1 (IGF-1) response vs placebo in acromegaly patients (pts) previously controlled with SoC (octreotide LAR/lanreotide Autogel). We report patient-reported outcome (PRO) data from an interim analysis of a Phase 3, open-label trial of CAM2029 (ACROINNOVA 2; NCT04125836). Methods: ACROINNOVA 2 enrolled pts with acromegaly who completed ACROINNOVA 1 (prior CAM2029 or placebo groups) and new pts with IGF-1 ≤2x upper limit of normal during stable SoC. Pts received once-monthly CAM2029 20 mg for up to 52 weeks (28 weeks for prior placebo pts [week 24−52]). Primary endpoint was adverse events. PROs were assessed using Acromegaly Index of Severity (AIS, 0−18; sum of 6 scores [0−3; none−severe] for headache, sweating, fatigue, joint pain, paresthesia, soft tissue swelling) for symptoms; Acromegaly Quality of Life Questionnaire (AcroQoL, 0−100) for QoL; Treatment Satisfaction Questionnaire for Medication (TSQM, 0−100) and patient satisfaction scale (0−5) for treatment satisfaction; and Self-Injection Assessment Questionnaire (SIAQ v2.0, 0−10) for satisfaction with self-administration. Higher scores signify improvements, except for AIS. Data are shown for the overall population. Results: At data cutoff (May 23, 2023), 54 roll-over pts (prior CAM2029 n=36; prior placebo n=18) and 81 new pts were enrolled; mean CAM2029 exposure was 56.3 weeks. CAM2029 was well tolerated with no unexpected side effects. Mean AIS score improved from baseline SoC to week 52 (−1.2; 95% CI: −1.8, −0.7); estimated proportion of pts with any acromegaly symptoms reduced by 15.1% (95% CI: −23.9, −6.3). At week 52 vs baseline: mean total AcroQoL increased by 3.5 (95% CI: 1.3, 5.7); mean TSQM increased for ‘convenience’ by 15.6 (95% CI: 11.8, 19.3), ‘effectiveness’ by 6.3 (95% CI: 2.8, 9.8), ‘satisfaction’ by 4.7 (95% CI: 1.1, 8.4), and for ‘side effects’ by 2.4 (95% CI: −2.0, 6.8). Mean patient satisfaction score at week 52 was 4.1 (95% CI: 3.9, 4.3); 32.6% and 19.3% of pts reported a ‘much better’ or ‘slightly better’ experience, respectively, with CAM2029 vs prior SoC. Mean SIAQ increased at week 48 vs pre-treatment, ‘satisfaction with way of taking medication’ by 1.6 (95% CI: 0.9, 2.2) and ‘feelings about injections’ by 0.8 (95% CI: 0.3, 1.3). Conclusion: CAM2029 improved symptom burden, QoL, treatment convenience, and patient satisfaction vs baseline SoC, including in pts with stable or controlled disease at baseline, supporting the clinical benefit of CAM2029 and its potential to address unmet needs for pts with acromegaly. Presentation: 6/2/2024

Survey on Patient Satisfaction with the Usability and Formulation of Budesonide Rectal Foam Following a Change in Head and Applicator Shape and Properties

Budesonide Rectal Foam (BF) was introduced in 2017 and changed in November 2022 upon request, addressing the challenges encountered with liquid rectal formulations indicated for ulcerative colitis (UC). This formulation is an important agent in the treatment of rectal to sigmoid colon lesions in moderate UC. As the characteristics of the formulation of the rectal formulation are thought to influence patient satisfaction, a survey was conducted on the formulation and patient satisfaction among patients who used BF before and after the change. The survey spanned from January 2023 to May 2023. As the primary endpoint, the same patients were evaluated on the Visual Analogue Scale (VAS) for patient satisfaction. Significant variations in formulation usability and patient satisfaction were observed in 20 eligible patients before and after the change (p<0.05). Patient satisfaction with the formulation was strongly correlated with formulation usability, ease of pushing the head, and ease of insertion (r>0.7). The change in packaging was thought to improve the usability of the formulation and patient satisfaction. The formulation's usability and ease of insertion had a clear influence on satisfaction with the rectal formulation.

Comparison of the Female Sexual Function Index, Beck Depression Inventory, and Patient Satisfaction Scale in Patients Undergoing Total Abdominal Hysterectomy and Single-Port Laparoscopic Hysterectomy for Benign Conditions

Aim: The uterus is widely accepted as a sexual organ, children-making body, secretory organ, youth, charm, or power supply by women. By hysterectomy, psychosocial problems such as fear of losing sexual identity occur, and depression may arise as a result of this. In this study, we investigated the effects of surgery on female sexual function and psychosocial situation according to the methods of Total Abdominal Hysterectomy (TAH) and Single Port Laparoscopic Hysterectomy (SPLH). Method: This prospective surgical study included 60 patients, including 30 SPLH and 30 TAH patients with benign reasons. The demographic data of patients, Female Sexual Function Inventory (FSFI) score, Beck Depression Questionnaire Scale, and Patient Evaluation Measurement (PEM) results were all assessed according to TAH and SPLH methods. Results: In the FSFI questionnaire, significant differences were found between SPLH and TAH groups for all "desire frequency," "desire level," "stimulation frequency," "stimulation level," and "stimulation trust" subquestions (p=0.004, p=0.0001, p=0.003, p=0.011 and p=0.011, respectively). In the Beck depression questionnaire, the TAH score (4.4±3.25) was significantly higher than the SPLH score (2.77±2.97) (p:0.047). TAH had 7.97±3.6 points, and SPLH had 3.73±1.1 points regarding treatment results (p:0.00017). Similarly, TAH had 14±4.4 points, while SPLH had 6.1±1.3 points regarding the functionality of hysterectomy (p

Global postural re-education versus Egoscue exercises in upper cross syndrome on neck pain, forward head and rounded shoulder posture: a randomised clinical trial

Abstract Upper crossed syndrome (UCS) is a condition that is caused due to alternating tightness and weakness in the opposite muscle groups of the neck, shoulders, and upper back which results in abnormal postural deviations. Global postural re-education (GPR) and Egoscue exercises (EE) aim to improve postural alignment and reduce musculoskeletal discomfort by maintaining certain postures. There is a lack of literature where these approaches are not compared and hence the need arises to evaluate their efficacy in the management of UCS. A randomised clinical trial was conducted on 34 individuals with UCS, where 17 individuals were randomly allocated into two groups, i.e. Group A (GPR) and Group B (EE). Both groups received conventional therapy (hot moist pack and interferential current therapy) 3 times/week for 4 weeks. Outcome measures like craniovertebral angle (CVA), pectoralis minor index (PMI), tragus to wall test (TTW), deep cervical flexors endurance, neck disability index (NDI), and patient satisfaction were assessed at baseline and on day 12 post-treatment. Within group analysis has shown statistical significant improvement in all the outcomes (). Between group analysis has shown both interventions to be equally effective in CVA (), PMI (), TTW (), deep cervical flexors endurance (), NDI () and patient satisfaction scale (PSS) () in individuals with UCS. In conclusion, both the interventions were equally effective and can be included in the protocol for the better outcomes in musculoskeletal dysfunctions. This present trial was prospectively registered in the Clinical Trial Registry of India with registration number CTRI/2023/10/059361.

High-powered 675-nm laser: Safety and efficacy in clinical evaluation and in vitro evidence for different skin disorders.

Laser technology is a viable therapeutic option for treating a number of skin pathologic conditions, including pigmented lesions, vascular lesions and acne scars. In this work, through in vitro and clinical investigationswe test the efficacy, the safety and the speed of treatment of high-powered laser system emitting a 675-nm in the management of various skin condition. In vitro experiments were performed irradiating adult human dermal fibroblasts cells (HDFa) with 675-nm laser for 24, 48 and 72h with different fluences and Ki-67+ cells were counted. The confocal microscopy images of control and treated samples were acquired. Clinical skin rejuvenation/diseases treatments with 675nm laser device were performed with different laser parameters in 11 patients with pigmented lesions, 5 patients with acne scars and 23 patients for skin rejuvenation. Data were evaluated with the validated global score using 5-point scales (GAIS) and patient's satisfaction scale. The application of the high-power 675nm laser has proven effective in stimulating cell proliferation in in vitro experiments and it led to good results for all skin pathologies. GAIS showed values between 3 and 4 points for all treated pathologies, all scores between '75%-good improvements' and '100%-excellent improvements'. The treatment time was reduced by 50% compared to the old parameters setting, resulting in a faster and good patient's satisfying technique. No serious adverse effects were recorded. the preclinical and clinical data confirm the efficacy and safety of this high-powered 675nm laser for several skin condition.

TURKISH VALIDITY AND RELIABILITY OF THE POUND SATISFACTION SCALE IN STROKE PATIENTS UNDERGOING REHABILITATION

Purpose: This study aimed to evaluate the Turkish validity and reliability of the Pound Satisfaction Scale (PSS). Methods: For the adaptation of the PSS to Turkish (PSS-Tr), the translation and back-translation process was carried out by following the international guidelines. Confirmatory factor analysis (CFA) was performed to measure structural validity. The relationship between PSS-Tr and the Patient Satisfaction Scale in Physiotherapy (PSSP) and the SF-36 was assessed for construct validity. Convergent validity was evaluated computing by the Average Variance Extracted (AVE). Cronbach's alpha coefficient and Composite reliability (CR) for internal consistency of the PSS-Tr and Bland-Altman plot and test-retest reliability analysis for temporal consistency were used. Results: The study included 130 stroke patients. The fit index values of the CFA showed that the structural validity of the PSS-Tr was appropriate (χ2/sd=1.779, RMSEA=0.075, GFI=0.911, AGFI=0.853, CFI=0.955, NFI=0.905). A high correlation was found between the PSS-Tr total score and the PSSP (p=0.001, r=0.672). A moderate correlation was found between the hospital satisfaction sub-dimension of PSS-Tr, and the sub-dimensions of SF-36 (p=0.001, r=0.484-0.609), while a low correlation was found between the home satisfaction sub-dimension of the PSS-Tr and the physical functioning (p=0.002, r=0.266) and physical role (p=0.035, r=0.180) sub-dimensions of SF-36. And also the PSS-Tr was found to have good internal (Cronbach alpha= 0.895, CR=0.94) and temporal consistency (ICC = 0.976). Conclusion: The Turkish version of the Pound Satisfaction Scale (PSS-Tr) is reliable and valid. The PSS-Tr may be useful for clinicians and researchers in assessing satisfaction with rehabilitation in stroke patients.

Development of a Video Consultation Patient-Satisfaction Questionnaire (vCare-PSQ): A Cross-Sectional Explorative Study.

Since the COVID-19 pandemic, the use of video consultation (VC) in primary care has expanded considerably in many countries. VC and other telehealth formats are often touted as a solution to improved health care access, with numerous studies showing high satisfaction with this care format among health professionals and patients. However, operationalization and measurement of patient satisfaction with VC varies across studies and often lacks consideration of dynamic contextual factors (eg, convenience, ease-of-use, or privacy) and doctor-patient relational variables that may influence patient satisfaction. We aim to develop a comprehensive and evidence-based questionnaire for assessing patient satisfaction with VC in general practice. The vCare Patient-Satisfaction Questionnaire (the vCare-PSQ) was developed according to the COSMIN (Consensus-Based Standards for the Selection of Health Measurement Instruments) guidelines. To achieve our overall objective, we pursued three aims: (1) a validation analysis of an existing patient-satisfaction scale (the PS-14), (2) an assessment of extrinsic contextual factors that may impact patient satisfaction, and (3) an assessment of pertinent intrinsic and relational satisfaction correlates (eg, health anxiety, information technology literacy, trust in the general practitioner, or convenience). For validation purposes, the questionnaire was filled out by a convenience sample of 188 Danish adults who had attended at least 1 VC. Our validation analysis of the PS-14 in a Danish population produced reliable results, indicating that the PS-14 is an appropriate measure of patient satisfaction with VC in Danish patient populations. Regressing situational and doctor-patient relational factors onto patient satisfaction further suggested that patient satisfaction is contingent on several factors not measured by the PS-14. These include information technology literacy and patient trust in the general practitioner, as well as several contextual pros and cons. Supplementing the PS-14 with dynamic measures of situational and doctor-patient relational factors may provide a more comprehensive understanding of patient satisfaction with VC. The vCare-PSQ may thus contribute to an enhanced methodological approach to assessing patient satisfaction with VC. We hope that the vCare-PSQ format may be useful for future research and implementation efforts regarding VC in a general practice setting.

Predictors of patient satisfaction to nursing service in government hospitals in eastern Visayas Philippines

This study assessed the patients’ satisfaction level on the nursing service in government hospitals within Eastern Visayas, Philippines and determined the predictors of patient’s satisfaction using Stepwise Multiple Regression Analysis. The researcher primarily employed a de-scriptive correlational research design. Further, a standardized questionnaire named Risser -Patient Satisfaction Scale was employed to 203 patient respondents. This study revealed that Patients have greater satisfaction level on the competencies or capabilities of nurses in their respective field. However, respondents were less satisfied on nurses’ attitude toward patients, and on how they communicate with them. Moreover, this study also revealed that age, ward assignment, and service type was found to be the predictors of patients’ satis-faction.

Advancements in Face and Neck Contouring: Integrating Radiofrequency-Assisted Liposuction with FaceTite and Buccal Fat Pad Excision for Facial Slimming

BackgroundThe integration of neck liposuction with FaceTite Manipulus Radiofrequency (RF) technology and buccal fat pad excision for enhanced neck rejuvenation promise heightened precision and efficacy in sculpting the neck and jawline. Neck liposuction, coupled with RF technology, provides controlled thermal energy for adipose tissue treatment and collagen remodeling, while buccal fat pad excision offers refined contouring of the lower face and neck. This integrated approach aims to optimize patient outcomes and advance the field of esthetic plastic surgery.MethodsA prospective study was conducted from 2016 to 2023 on 80 consecutive patients who presented to the author's private clinic and required neck remodeling surgery for esthetic purposes. Patients were monitored and clinic appointments were scheduled at intervals of 0, 1, 3, 6 and 12 months post-treatment for evaluation. A tape measure recorded submental length at 1 and 6 months, and a satisfaction survey was administered one week before surgery and after six months. Physicians assessed improvement using a five-point scale for patient satisfaction and a four-point scale for overall improvement.ResultsAll patients underwent successful RFAL treatment, consistently achieving satisfaction with the outcomes. The average reduction in submental length measured 23 mm during the 6-month follow-up period. Additionally, the removal of buccal fat pads played a pivotal role in facial slimming and enhancing the esthetics of the upper cheek region.ConclusionsThe integration of neck liposuction with FaceTite RF technology and buccal fat pad excision offers a promising approach for enhanced neck rejuvenation and facial contouring. This combined method demonstrates heightened precision and efficacy in sculpting the neck and jawline, aiming to optimize patient outcomes and advance the field of esthetic plastic surgery.Level of Evidence IVThis journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.